medRxiv PreprintsInternational16 November 2026
Fentanyl dabbing with cannabis retail equipment: an ethnographic and drug-checking study
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Fentanyl's entrenchment in U.S. West Coast drug markets brought a shift from injecting to smoking illicit opioids. We characterize the next transition: the rise of 'dabbing,' vaporizing fentanyl with equipment sold for cannabis concentrates. Methods: This mixed-methods study combined ethnographic interviewing and participant observation among people who use fentanyl in California and Oregon (2024-2026) with survey data from a Los Angeles drug checking program. After identifying dabbing ethnographically, we added an optional smoking-method item to the survey. Results: Of 108 partici
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.